Ignite Creation Date:
2024-05-05 @ 11:58 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00193258
Status:
COMPLETED
Last Update Posted:
2013-01-31
First Post:
2005-09-12
Brief Title:
Bevacizumab Erlotinib and Imatinib in the Treatment of Advanced Renal Cell Carcinoma
Sponsor:
SCRI Development Innovations LLC
Organization:
SCRI Development Innovations LLC